Neural imaging—maps of brain functions—is a primary tool used by researchers hoping to transform the lives of people living with chronic neurological conditions such as epilepsy. At present, researchers often require several different imaging techniques to fully map brain functions, making research and treatment of these conditions expensive and inefficient.
Using cutting-edge illumination technology, Prof. Ofer Levi and his research students from the Institute of Biomaterials & Biomedical Engineering (IBBME) and The Edward S. Rogers Sr. Department of Electrical & Computer Engineering (ECE) at the Univ. of Toronto has developed a new cost-effective neural imaging system. It allows researchers to make much more complex maps of the brain with just one camera and one imaging system. The team's initial findings, released this week in Biomedical Optics Express, demonstrate that this new technology may one day transform the way researchers view the human brain.
Developed from the same technology that lights up our cell phones and computers, this unique system uses Vertical Cavity Surface Emitting Lasers (VCSEL): low-cost, easily-tested, miniature microchip lasers mounted on an extremely fast, sensitive camera, which allows the operator to switch the lasers on and off with extraordinary speed and precision. This rapid light manipulation (at a rate of approximately 1x/millisecond) means that the brain can be mapped with greater sophistication and precision—much more quickly. Results published in Levi's article, for instance, demonstrate that this imaging technology is able to classify both veins and arteries simultaneously—something never before accomplished. . .View Full Article
"CPRX has a few programs in indications that are less crowded and do not have many successful treatment options." (11/26/13) Catalyst Pharmaceutical Partners Inc. - The Life Sciences Report Interview with Michael Hay More >
"ATHX's MultiStem phase 2 data are going to be very important for investors if the trial is positive for patients." (11/26/13) Athersys Inc. - The Life Sciences Report Interview with Michael Hay More >
"We expect FDA approval in the near term—likely by the end of the year—for OCLS' Microcyn Hydrogel device." (11/26/13) Oculus Innovative Sciences Inc. - The Life Sciences Report Interview with Jocelyn August More >
Technology Improves Neural Imaging, Human Brain Research
Source: Laboratory Equipment (4/2/12)
"A new cost-effective neural imaging system allows researchers to make much more complex maps of the brain with just one camera and one imaging system."
"CYTX's upcoming ATHENA clinical data will be a major catalyst for the company, giving confidence not only to investors but also to the physician community." (11/14/13) Cytori Therapeutics Inc. - The Life Sciences Report Interview with Joseph Pantginis More >
"INO has extraordinary potential; I really want to see CEO Joseph Kim and Dave Weiner push this technology into the future." (10/24/13) Inovio Pharmaceuticals Inc. - The Life Sciences Report Interview with Patrick Cox More >
"CPRX is an emerging biotechnology company in the white hot space of orphan drug medicines." (11/7/13) Catalyst Pharmaceutical Partners Inc. - The Life Sciences Report Interview with Scott Henry More >
"BDSI's buprenorphine product for chronic pain could be a $500M+/year revenue-generating drug if approved." (11/7/13) BioDelivery Sciences International Inc. - The Life Sciences Report Interview with Scott Henry More >